Want to stay updated on the latest mining news?

Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu RxConnect® pharmacies to support patient access

- Advertisement -
- Advertisement -
- Advertisement -